Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

  • Healthcare Events

      Middle East

    • Arab Health
    • Medlab Middle East
    • Patient Safety
    • CPhI MEA
    • Global Health Exhibition

      Asia

    • Medlab Asia
    • Asia Health

      Africa

    • Africa Health
    • Medic West Africa

      Americas

    • FIME
    • ExpoMed
    • Hospitalar
  • Omnia Health Insights
  • Omnia Health Marketplace
  • About us
Medlab ME
 
Medlab Middle East Event Logo
  • Overview
    • Show information
    • Our safety commitment
    • Industry reports
    • Resource centre
    • FAQs
    • Contact us
  • Exhibit
    • Why exhibit?
    • Who attends?
    • Download sales brochure
    • Venue Branding Opportunities Brochure
    • Book a stand
    • Sponsorship opportunities
  • Congress
    • Overview
    • Chairs
    • Track prices
    • Enquire now
  • Visit
    • Register your interest
    • Why visit?
    • Product categories
    • Online - New contacts and free educational sessions
  • Travel
    • Hotel
    • Venue
    • Visa
  • Stand enquiry
  • HOME
  • Media
  • Press Releases
  • Neuberg Diagnostics & OptraSCAN® announce the launch of Global TELEPath™ Network in UAE, India and South Africa through a joint venture

Neuberg Diagnostics & OptraSCAN® announce the launch of Global TELEPath™ Network in UAE, India and South Africa through a joint venture

New venture “Neuberg DIGIPATH, Powered by OptraSCAN® Inc.” to focus on providing advanced and affordable digital pathology solutions

Dubai, 5th February 2019: Neuberg Diagnostics, one of the Top 4 Diagnostics Service Provider in India and OptraSCAN® Inc., the US-based global digital pathology solutions provider today announced launching of Global TELEPath™ Network for the pathologist community in UAE, India and South Africa under a new joint venture namely, “Neuberg DIGIPATH, Powered by OptraSCAN®Inc.” The joint venture is in initial phase and will be formed in three months. The announcement was made at the annual event for the international medical laboratory community, MedLab 2019 in Dubai, United Arab Emirates. The Global TELEPath™ Network, promoted by OptraSCAN was launched in US and European region last year.

 

The joint venture combines the exceptional histopathology and cytology services provided by Neuberg Diagnostics with advanced digital pathology capabilities offered by OptraSCAN and brings to the table a whole new array of services related to digitization of tissue slides and telepathology with an objective of making new-age life-saving healthcare technology available to the human kind. The JV promises access to a large pool of histopathologists – who diagnose and study diseases using expert medical interpretation of cells and tissue samples – from UAE, India and South Africa. Histopathology is, among other applications, integral to cancer management through the staging and grading of tumours.

 

“Neuberg’s vision has always been to deploy the most advanced technologies assisted by data science and artificial intelligence tools. This has brought some of the best pathologists, biochemists, geneticists, microbiologists and several other clinical lab professionals from around the world to work closely, sharing knowledge and using the latest generation of diagnostics techniques”, said Dr. GSK Velu, Founder & Chairman, Neuberg Diagnostics. “With OptraSCAN’s expertise in providing new-age technology that are well-equipped with AI & ML based analysis tools, the newly combined organization will enable us to expand the service as well as the geographic reach of Neuberg's existing lab services. We expect the economies of scale from this partnership to help us bring better value to our clients and expand our service offerings.”

 

This new venture ‘Neuberg DIGIPATH, Powered by OptraSCAN® Inc.’ services comprise of digitization of tissue slides, storage and archiving, slide discussions and digital learning modules, automated slide processing platforms and second-opinion tele-consulting services. Apart from user-friendly features like a compact, high-resolution and cloud-ready platform with smart-recognition facilities, the new entity promises an economically priced “walk-away technology” for the healthcare sector. The partners intend to provide labs with cutting-edge technology using the following products and services 

 

  1. OptraSCAN’s 15-slide Brightfield Digital Pathology Scanner
  2. OptraSCAN’s Image Management tools
  3.  OptraSCAN’s Telepathology Software platform and second Opinion Services through a teleportal to be launched with NeubergDigiPath.com
  4. Neuberg’s own Histopathology Network based in India / Middle East & Africa  
  5. Enrolling world class histopatholgists for second Opinion Services through a TelePath Site called NeubergDigipath.com
  6. Cost Effective Neutral digitization services for all healthcare institutions and patients in all key locations where Neuberg network is present
  7.  Digital Sharing and Learning platform for practicing Pathologists & Pathology Students using Data Analytics, Artificial Intelligence Tools and Digital Slide Library  

 

“We are delighted to be partnering with Neuberg Diagnostics. This new venture, ‘Neuberg DIGIPATH, Powered by OptraSCAN® Inc.’, is the next step forward in a healthcare collaboration that combines the expertise and capabilities of OptraSCAN with Neuberg Diagnostics to provide advanced and affordable digital pathology products in India, Middle East, Africa and beyond,” said Mr. Abhi Gholap, Founder & CEO, OptraSCAN. “OptraSCAN’s Global TELEPath™ Network has great market traction in USA and European region, so this venture is also a part of our global strategy to create innovative healthcare affiliations with leading healthcare providers around the globe to enhance our reach in untapped regions.”

 

Through this partnership joint venture, both the companies aim to expand their market base and have planned a phase and region-wise expansion. In phase-I, the JV intends to launch its products and services in UAE, India and South Africa; followed by Phase-II, wherein it hopes to expand their offerings to Rest of Asia, Europe and the rest of Africa. The JV partners intend to make on-demand cutting-edge digital pathology solutions available to leading hospitals in the Middle East region thus taking healthcare and diagnostics deep into the digital age.

 

“Digital pathology – the future scope of pathology opens up new vistas to daily reporting, expert opinions, peer consults, quality assessment, storage and artificial intelligence NEUBERG DIGIPATH builds bridges along this journey with complete digital pathology solutions” says Dr. Jayaram, the Head of Histopathology & Cytology Services of Neuberg Diagnostics Network. 

 

 

- Ends -

Diamond partner

  • Abbott

Platinum partners

  • Beckman Coulter
  • Biomerieux Diagnostics
  • Fujifilm

Gold partner

  • Horiba

Silver partners

  • Bioperfectus
  • Sansure

Official hygiene partners

  • Gojo
  • Purell

Knowledge partner

Supporting bodies

  • UAE Ministry of Health and Prevention
  • Government of Dubai
  • Dubai Health Authority
  • Health Authority Abu Dhabi
  • Dubai Healthcare City Authority
  • ENA
  • College of American Pathologists
  • Saudi Clinical Chemistry
  • ISBT
  • Saudi Society of Laboratory Sciences

Official airline partner

  • Emirates

Official hospitality partner

  • OnPeak

Official exhibitor directory

  • Omnia

Quick Links

  • Register your interest |
  • Stand enquiry

Contact Us

[email protected]

Online

23 May - 22 July 2021: 9:00 – 18:00

Live

21 June 2021: 09:30 - 18:00
22 June 2021: 09:30 - 18:00
23 June 2021: 09:30 - 18:00
24 June 2021: 09:30 - 17:00

VAT

The UAE has introduced the implementation of Value Added Tax effective 1 January 2018 at a rate of 5%. Conferences that take place in the UAE are liable to Value Added Tax under ‘Federal Decree-Law No. (8) of 2017, which will be reflected on all conference fees.

More information on UAE VAT regulations can be obtained by clicking here

Caution

Beware of unsolicited websites and companies. Only the official Medlab Middle East registration forms can confirm your participation at the show. The list of official suppliers can be seen here.


Medlab Middle East will be organised in accordance with Informa’s AllSecure health and safety standard.

Our global reach in Healthcare

Whether in person or online we enable deeper learning, relationships and decisions.
Staging 12 live and online exhibitions, 110 conferences and reaching over 700,000 healthcare professionals, we are where the world of healthcare meets.

Together for a healthier world 

  • Arab Health, Dubai, UAE
  • Medlab Middle East, Dubai, UAE
  • Medlab Asia, Bangkok, Thailand
  • Asia Health, Bangkok, Thailand
  • FIME, Miami Beach, USA
  • Medic West Africa, Lagos, Nigeria
  • Global Health, Riyadh, Saudi Arabia
  • CPHI MEA, Riyadh, Saudi Arabia
  • Africa Health, Johannesburg, South Africa
  • Patient Safety, Dubai, UAE
  • Hospitalar, Sao Paulo, Brazil
  • Expo Med, Mexico City, Mexico
  • Omnia Health Marketplace
  • Omnia Health Insights
Informa Markets

Copyright © 2020. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions